title: Delayed HIV-1 seroconversion after antiretroviral therapy.
authors.forename: C
authors.initials: C
authors.lastname: Apetrei
authors.forename: C
authors.initials: C
authors.lastname: Tamalet
authors.forename: C
authors.initials: C
authors.lastname: Edlinger
authors.forename: F
authors.initials: F
authors.lastname: Damond
authors.forename: D
authors.initials: D
authors.lastname: Descamps
authors.forename: A G
authors.initials: AG
authors.lastname: Saimot
authors.forename: F
authors.initials: F
authors.lastname: Brun-Vézinet
authors.forename: F
authors.initials: F
authors.lastname: Simon
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015153:Blotting, Western; D004359:Drug Therapy, Combination; D015483:HIV Antibodies / Q000097:blood; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy*; D006679:HIV Seropositivity; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D012367:RNA, Viral / Q000032:analysis
chemical_list: D019380:Anti-HIV Agents; D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D012367:RNA, Viral